Clinical Trial Update: Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD) [NA]

View source ↗

Summary

A University of Milan-sponsored clinical trial for CDKL5 deficiency disorder is currently recruiting to evaluate a gut-targeted strategy aimed at improving seiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cdkl5 Deficiency Disorder

Drugs mentioned

• Unspecified therapy

Snippet

Sponsor: University of Milan | Conditions: CDKL5 | NA | Status: RECRUITING